Почетна › Немалоклетни карцином плућа › Konektikat › New Haven
Kliničke studije za Немалоклетни карцином плућа u gradu New Haven, CT
40 studija za Немалоклетни карцином плућа traži učesnike na lokacijama u gradu New Haven i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
Тражи се учесникФаза 1/2
- Yale University, New Haven
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Тражи се учесникФаза 3
- Yale University, New Haven
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 3 ми удаљено
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 ми удаљено
- и још 2
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Тражи се учесникФаза 2
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale-New Haven Hospital-Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
- и још 1
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Тражи се учесникФаза 1
- Yale Cancer Center, New Haven
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Тражи се учесникФаза 3
- Yale University School of Medicine ( Site 0201), New Haven
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Тражи се учесникФаза 3
- Smilow Cancer Center at Yale-New Haven ( Site 3253), New Haven
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Тражи се учесникФаза 1
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
Тражи се учесникФаза 1/2
- Yale Cancer Center, New Haven
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Тражи се учесникФаза 1/2
- Yale University - Cancer Center, New Haven
SI-B036-ST-101 in Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1
- Yale Cancer Center, New Haven
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Тражи се учесникФаза 3
- Yale University School of Medicine, New Haven
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Тражи се учесникФаза 1
- Yale Cancer Center, New Haven
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Тражи се учесникФаза 2
- Yale University, New Haven
M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors
Тражи се учесникФаза 1
- Yale Cancer Center, New Haven
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Тражи се учесникФаза 1/2
- Yale New Haven Hospital, Yale Cancer Center, New Haven
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Тражи се учесникФаза 3
- Research Site, West Haven · 3 ми удаљено
Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma
Тражи се учесникФаза 2
- Yale University, New Haven
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 2
- Yale Cancer Center, New Haven
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Тражи се учесникФаза 2
- Research Site, New Haven
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 2
- Smilow Cancer Hospital at Yale - New Haven, New Haven
- Yale-New Haven Hospital- Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
- и још 1
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Тражи се учесникФаза 1/2
- Yale University School of Medicine - Yale Cancer Center, New Haven
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Тражи се учесникФаза 2
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 ми удаљено
- Smilow Cancer Hospital-Derby Care Center, Derby · 8 ми удаљено
- и још 1
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Тражи се учесникФаза 2
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 ми удаљено
- Smilow Cancer Hospital-Derby Care Center, Derby · 8 ми удаљено
- и још 1
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Тражи се учесникФаза 1/2
- Yale University, New Haven
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Тражи се учесникФаза 2/3
- Yale University, New Haven
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 3 ми удаљено
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 ми удаљено
- и још 2
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- Yale Cancer Center, New Haven
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Тражи се учесникФаза 1
- Exelixis Clinical Site #62, New Haven
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Тражи се учесникФаза 1
- Yale University, Yale Cancer Center, New Haven
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Тражи се учесникФаза 1
- Yale Cancer Center, New Haven
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1
- Yale Cancer Center, New Haven
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Тражи се учесникФаза 1
- Yale Cancer Center, New Haven
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Тражи се учесникФаза 3
- Research Site, New Haven
Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer
Тражи се учесникФаза 1/2
- Smilow Cancer Hospital, New Haven
- Smilow Cancer Hospital - Hamden Care Center, Hamden · 6 ми удаљено
- Smilow Cancer Hospital Care Center - Guilford, Guilford · 13 ми удаљено
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Тражи се учесникФаза 1
- Yale University School of Medicine /ID# 225707, New Haven
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Тражи се учесникФаза 1
- Smilow Cancer Hospital (Yale University), New Haven
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Тражи се учесникФаза 2
- Yale University, New Haven
- Smilow Cancer Hospital-Orange Care Center, Orange · 5 ми удаљено
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 ми удаљено
- и још 2
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Тражи се учесникФаза 1
- Yale University, New Haven
Repositioning Immunotherapy in VetArans With Lung Cancer
Тражи се учесникФаза 2
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven · 3 ми удаљено
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Тражи се учесникФаза 1/2
- Yale University, New Haven
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Тражи се учесникФаза 1/2
- Yale Cancer Center, New Haven
Studije za Немалоклетни карцином плућа u drugim gradovima
- Houston, TX143 студија
- New York City, NY123 студија
- Arlington, VA111 студија
- Nashville, TN97 студија
- Los Angeles, CA92 студија
- Boston, MA87 студија
- St. Louis, MO68 студија
- Baltimore, MD60 студија
- San Antonio, TX60 студија
- Chicago, IL59 студија
- Columbus, OH57 студија
- Seattle, WA55 студија
Ostale studije u gradu New Haven
- Рак дојке38 студија
- Рак (све врсте)35 студија
- Рак плућа24 студија
- Колоректални карцином23 студија
- Плоскоклеточни карцином главе и врата22 студија
- Метастатски карцином22 студија
- Рак простате22 студија
- Рак јајника20 студија
- Предозирање опиоидима19 студија
- Akutna mijeloidna leukemija18 студија
- Poremećaj upotrebe alkohola (AUD)18 студија
- Trostruko negativni rak dojke16 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.